@FierceBiotech: Amgen takes another stride in frenzied race toward the PCSK9 finish line. More | Follow @FierceBiotech
@JohnCFierce: Triple shot IL-13/IL-4 -- Promising asthma trial prompts Regeneron, Sanofi to push dupilumab into PhIII. More | Follow @JohnCFierce
@DamianFierce: I had missed this excellent tick-tock of the last days of one Christopher A. Viehbacher. More | Follow @DamianFierce
> Acadia disappointed investors with the news that it will delay its planned NDA for the Parkinson's drug pimavanserin (Nuplazid). The biotech--which recently won 'breakthrough' status for the treatment--now plans to file in the first quarter of 2015. Its shares were down 3% this morning. Release
> Australia's Alchemia says CEO Thomas Liquard has left the company and will be temporarily replaced by non-executive chairman Tracie Ramsdale. Release
Medical Device News
@FierceMedDev: China FDA's new medical device importation regulations shorten review period. More | Follow @FierceMedDev
@VarunSaxena2: Device that performs hundreds of tests with a single drop of blood wins Nokia Sensing Xchallenge. More | Follow @VarunSaxena2
> Thync rolling out wearable, noninvasive device to elevate mood with fresh infusion of cash in tow. More
> Medtronic makes concessions to European regulator in bid to close Covidien deal. News
> OrthAlign secures $15M to launch new navigation system for orthopedic surgery. Article
Pharma News
@FiercePharma: Top-read special report: The top 10 pharma companies by 2013 revenue. More | Follow @FiercePharma
@EricPFierce: Fresenius Russian partnership tanks even as Russian tanks spotted rolling into Ukraine. Story | Follow @EricPFierce
@CarlyHFierce: Dendreon bankruptcy weighs on cancer vaccine field. More | Follow @CarlyHFierce
> Take as directed? U.K. health service teams with academics, pharmacy on drug adherence. News
> Merck's head-to-head Vytorin trial might be surprisingly flattering. More
Biotech Research News
> Small human study will test a new approach to fighting diabetes. More
> Research team points to Sestrin 3 as a potential new target in diabetes. Article
> Harvard investigators prep an animal study of CRISPR Cas tech for HIV. Story
> Swiss team at ETH spotlights potential of a new antibiotic found in nature. More
> Genentech R&D team fixes a flawed approach to Alzheimer's. Report
Pharma Manufacturing News
> Cadila API plant slapped for faulty follow-up on stinking APIs. Article
> Dr. Reddy's, Endo benefit from Ranbaxy manufacturing shortfalls. Item
> Plant power outage zaps the juice from AMRI's earnings. More
> Dendreon, done in by expensive, complex manufacturing, files for bankruptcy. Story
> Fresenius expansion plans in Russia sidelined by political turmoil. Article